Skip to main content
SpringerLink
Log in

Can Our Guts Tell Us Anything About MS?

  • LETTER TO THE EDITOR
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Branton WG, Lu JQ, Surette MG, Holt RA, Lind J, Laman JD, Power C (2016) Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis. Sci Rep 6:37344

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Buscarinu MC, Cerasoli B, Annibali V et al (2017) Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study. Mult Scler 23:442–446

    Article  PubMed  Google Scholar 

  • Camara C, Greenfield J, Silva C, Metz L, Yong VW (2018). Serum intestinal fatty acid binding protein in multiple sclerosis as a marker of intestinal barrier integrity [abstract]. Presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Berlin, October 10–12, 2018. In ECTRIMS Online Library; Abstract P529

  • Camara-Lemarroy CR, Metz L, Meddings JB, Sharkey KA, Wee Yong V (2018) The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Brain 141:1900–1916

    Article  PubMed  PubMed Central  Google Scholar 

  • Dickens AM, Larkin JR, Griffin JL et al (2014) A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Neurology 83:1492–1499

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Escribano BM, Medina-Fernández FJ, Aguilar-Luque M et al (2017) Lipopolysaccharide binding protein and oxidative stress in a multiple sclerosis model. Neurotherapeutics 14:199–211

    Article  CAS  PubMed  Google Scholar 

  • González-Oria MC, Márquez-Coello M, Girón-Ortega JA, Argente J, Moya M, Girón-González JA (2019) Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects. J Neuroimmune Pharmacol. Published online 2019 Jan 16. https://doi.org/10.1007/s11481-018-09832-z

  • Grootjans J, Thuijls G, Verdam F, Derikx JP, Lenaerts K, Buurman WA (2010) Non-invasive assessment of barrier integrity and function of the human gut. World J Gastrointest Surg 2:61–69

    Article  PubMed  PubMed Central  Google Scholar 

  • Kartaram S, Mensink M, Teunis M et al (2018) Plasma citrulline concentration, a marker for intestinal functionality, reflects exercise intensity in healthy young men. Clin Nutr S0261-5614:32467–32461

    Google Scholar 

  • Yacyshyn B, Meddings J, Sadowski D, Bowen-Yacyshyn MB (1996) Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability. Dig Dis Sci 41:2493–2498

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, 1403 29 Street NW, Calgary, AB, T2N 2T9, Canada

    Carlos R. Camara-Lemarroy

  2. The Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, 1403 29 Street NW, Calgary, AB, T2N 2T9, Canada

    Carlos R. Camara-Lemarroy

Authors
  1. Carlos R. Camara-Lemarroy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlos R. Camara-Lemarroy.

Ethics declarations

Conflict of Interest

The author declares no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Camara-Lemarroy, C.R. Can Our Guts Tell Us Anything About MS?. J Neuroimmune Pharmacol 14, 367–368 (2019). https://doi.org/10.1007/s11481-019-09841-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-019-09841-6

Search

Navigation